USMLE Step 1 Immunology High-Yield Facts

Immunology is a foundational pillar for USMLE Step 1, integrating with microbiology, pathology, and pharmacology. Mastering its principles allows you to correctly diagnose immune system dysfunctions—from rampant infections to self-directed attacks—and predict treatment responses. This guide consolidates the high-yield facts you must know, framing them within the clinical reasoning required for the exam.

Hypersensitivity Reactions: The Four Types of "Over-Reaction"

Hypersensitivity reactions represent inappropriate or excessive immune responses to an antigen. Categorizing them correctly is a classic Step 1 task, as each type has distinct mechanisms, timelines, and clinical examples.

Type I (Immediate/IgE-mediated) occurs within minutes. An allergen cross-links IgE antibodies bound to mast cells and basophils, triggering degranulation and release of histamine, leukotrienes, and other mediators. This causes conditions like allergic rhinitis, asthma, anaphylaxis, and atopic dermatitis. The key mediators to know are histamine (causing vasodilation and bronchoconstriction) and leukotrienes (potent bronchoconstrictors).

Type II (Antibody-mediated/Cytotoxic) involves IgG or IgM antibodies directed against antigens on the surface of a patient's own cells. This leads to cell destruction via complement activation (forming the Membrane Attack Complex, or MAC) or antibody-dependent cellular cytotoxicity (ADCC) by natural killer (NK) cells. Classic examples include autoimmune hemolytic anemia, Goodpasture syndrome (anti-basement membrane), and acute hemolytic transfusion reactions.

Type III (Immune complex-mediated) occurs when antigen-antibody (Ag-Ab) complexes deposit in tissues, activating complement and attracting neutrophils, which cause inflammatory damage. Serum sickness (from drugs like penicillin or antitoxins) is a systemic prototype, while Arthus reaction (local skin necrosis) and autoimmune diseases like SLE (with anti-dsDNA antibodies causing glomerulonephritis and vasculitis) are key associations.

Type IV (Delayed-type/Cell-mediated) is T-cell driven, peaking 48-72 hours after exposure. It does not involve antibodies. CD4+ T-helper 1 (Th1) cells release cytokines like IFN-γ to activate macrophages in reactions to tuberculin (PPD test) or contact dermatitis (e.g., poison ivy). CD8+ cytotoxic T lymphocytes directly kill target cells, as seen in contact dermatitis to metals and in transplant rejection.

Immunodeficiency Presentations: Clues from Clinical History

Immunodeficiencies present with recurrent, severe, or unusual infections. The pattern of infection is your diagnostic roadmap, pointing to the deficient arm of the immune system.

B-cell (Humoral) Deficiencies lead to recurrent pyogenic bacterial infections (e.g., Streptococcus pneumoniae, Haemophilus influenzae) of the sinuses, lungs, and ears. Patients also have trouble with gastrointestinal viruses (e.g., enteroviruses) and parasites like Giardia. Key examples include X-linked agammaglobulinemia (Bruton's tyrosine kinase defect; absent B cells and all immunoglobulin classes) and Common Variable Immunodeficiency (CVID; low immunoglobulins despite presence of B cells).

T-cell (Cellular) Deficiencies result in severe infections with intracellular pathogens, including viruses (HSV, VZV, CMV), fungi (Candida, Pneumocystis jirovecii), and atypical bacteria (Mycobacterium). DiGeorge syndrome (22q11.2 deletion, failure of 3rd & 4th pharyngeal pouch development) with thymic aplasia is the classic example, presenting with hypocalcemia (from parathyroid aplasia), cardiac defects, and characteristic facies.

Combined B- and T-cell Deficiencies are the most severe. Severe Combined Immunodeficiency (SCID) presents in infancy with failure to thrive and life-threatening infections from all pathogen types. Causes include adenosine deaminase deficiency (toxic metabolite buildup) and IL-2 receptor gamma chain defects (X-linked). The "bubble boy" disease is a hallmark.

Complement Deficiencies have specific patterns: deficiencies in early components (C1-C4) are linked to autoimmune phenomena like SLE (especially C2, C4), while deficiencies in late components (C5-C9) increase susceptibility to recurrent Neisseria infections (meningitis, gonorrhea). C3 deficiency causes severe recurrent pyogenic infections, and C1 esterase inhibitor deficiency causes hereditary angioedema.

The Complement System and Key Cytokine Functions

The complement system is a cascade of plasma proteins that opsonize pathogens, recruit inflammatory cells, and lyse microbes. You must distinguish the three pathways:

• Classical Pathway: Activated by Ag-Ab complexes (IgG or IgM). C1 binds, leading to C3 convertase (C4b2a).
• Alternative Pathway: Activated by microbial surfaces (e.g., LPS). Spontaneous hydrolysis of C3 ("tickover") leads to C3 convertase (C3bBb).
• Lectin Pathway: Activated by mannose-binding lectin binding to microbial sugars, leading to the same C3 convertase as the classical pathway (C4b2a).

All pathways converge at C3, forming C5 convertase and the Membrane Attack Complex (MAC: C5b-9), which creates pores in target cell membranes. Key functions are opsonization (C3b), chemotaxis (C5a), and anaphylatoxin activity (C3a, C5a) causing mast cell degranulation.

Cytokines are signaling molecules critical for immune cell communication. For Step 1, know these key players:

• IL-1 & TNF-α: Pro-inflammatory; cause fever, activate endothelium (sepsis/shock).
• IL-2: Promotes T-cell proliferation (autocrine); target of immunosuppressants.
• IL-4: Drives B-cell class switching to IgE; differentiates naive T-helper cells to Th2.
• IL-5: Promotes eosinophil growth and activation (important in parasitic infections and asthma).
• IFN-γ: Secreted by Th1 and NK cells; activates macrophages; deficiency causes susceptibility to mycobacterial infections.
• IL-10: Anti-inflammatory; inhibits Th1 and macrophage activity.
• IL-12: From macrophages; promotes Th1 differentiation.
• TGF-β: Generally anti-inflammatory; promotes IgA class switching and T-regulatory cell function.

Immunoglobulin Classes and Lymphocyte Development

Each immunoglobulin class has a unique structure and function:

• IgG: Most abundant in serum; crosses placenta (passive immunity to neonate); opsonizes; activates complement. Four subclasses.
• IgA: Found in secretions (mucus, tears, breast milk) as a dimer; mucosal immunity.
• IgM: Pentamer; first antibody produced in a primary immune response; efficient complement activator.
• IgD: Functions as a B-cell receptor.
• IgE: Bound to mast cells and basophils; mediates Type I hypersensitivity and defense against helminths.

Lymphocyte development is a tightly regulated process. B cells mature in the bone marrow, where they undergo V(D)J recombination to generate diverse antigen receptors. Negative selection eliminates self-reactive clones. T-cell precursors migrate to the thymus. In the thymic cortex, they undergo positive selection (for MHC restriction) and in the medulla, negative selection (against self-reactivity). The "double-negative" (CD4-, CD8-) stage precedes the "double-positive" (CD4+, CD8+) stage before final commitment to CD4+ or CD8+ single-positive T cells.

Transplant Rejection, Autoimmunity, and Drug Targets

Transplant rejection types are defined by timing and mechanism:

• Hyperacute: Minutes to hours; pre-existing antibodies against donor antigens (e.g., ABO mismatch) cause Type II hypersensitivity.
• Acute: Weeks to months; primarily Type IV hypersensitivity with CD8+ cytotoxic T-cells attacking donor MHC.
• Chronic: Months to years; vascular fibrosis and intimal thickening from chronic inflammation; often antibody-mediated.

Autoimmune disease mechanisms include molecular mimicry (e.g., rheumatic fever after S. pyogenes infection), release of sequestered antigens (e.g., trauma to the eye revealing lens proteins), and loss of regulatory T-cell function. HLA associations are high-yield (e.g., HLA-B27 with ankylosing spondylitis, HLA-DR2 with MS and SLE).

Immunosuppressive drugs target specific immune activation steps:

• Calcineurin Inhibitors (Cyclosporine, Tacrolimus): Block IL-2 production in T-cells.
• Antiproliferatives (Azathioprine, Mycophenolate): Inhibit lymphocyte DNA synthesis.
• mTOR Inhibitor (Sirolimus): Blocks IL-2 receptor signaling.
• Corticosteroids (Prednisone): Broad anti-inflammatory; inhibit phospholipase A2 and NF-κB.
• Biologics: Monoclonal antibodies like anti-TNF-α (infliximab) for autoimmune diseases.

Common Pitfalls

1. Confusing Hypersensitivity Types: Students often mistake the effector mechanism. Remember: Type I = IgE/mast cells; Type II = IgG/IgM vs. cell surface; Type III = Immune complex deposition; Type IV = T-cells. Associate classic clinical examples firmly with each type.
2. Mixing Up Immunodeficiency Patterns: Attributing recurrent Neisseria infections to a B-cell defect is a common error. This pattern points to a terminal complement deficiency (C5-C9). Pyogenic bacteria → think B-cell/humoral; intracellular/viral/fungal → think T-cell/cellular.
3. Misinterpreting Transplant Rejection Pathology: Hyperacute rejection is antibody-mediated (Type II), not T-cell mediated. The histology shows thrombosis and necrosis, not a lymphocytic infiltrate, which is characteristic of acute rejection.
4. Overlooking HLA Associations: Forgetting the classic HLA-disease links can cost you easy points. Drill the high-yield pairs: HLA-B27 (ankylosing spondylitis, reactive arthritis), HLA-DR2 (MS, SLE), HLA-DR3 (SLE, Type 1 DM), HLA-DR4 (RA, Type 1 DM).

Summary

• Hypersensitivity reactions are categorized into four distinct types (I-IV) based on mechanism, timing, and key mediators/effector cells.
• The pattern of recurrent infections is diagnostic: pyogenic bacteria suggest B-cell deficiency, intracellular/viral/fungal suggest T-cell deficiency, and Neisseria suggests terminal complement deficiency.
• The complement system has three initiating pathways (classical, alternative, lectin) that converge at C3, leading to opsonization, inflammation, and cell lysis via the MAC.
• Immunoglobulins have specialized roles: IgG (serum, placental transfer), IgA (secretions), IgM (primary response), IgD (BCR), and IgE (allergy/helminths).
• Transplant rejection types are hyperacute (pre-formed Abs), acute (T-cell mediated), and chronic (vascular scarring). Autoimmunity arises from mechanisms like molecular mimicry and loss of self-tolerance.